Literature DB >> 17593072

Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage.

E M van Soest1, M C J M Sturkenboom, J P Dieleman, K M C Verhamme, P D Siersema, E J Kuipers.   

Abstract

BACKGROUND: Upper gastrointestinal (UGI) complications are a well-recognized risk of NSAID treatment, requiring preventive measures in high-risk patients. Adherence to gastroprotective agents (GPAs) in NSAID users has been suggested to be suboptimal. AIM: To investigate the association between adherence to GPAs (proton pump inhibitors or H(2)-receptor antagonists) and the risk of NSAID-related UGI ulcers or haemorrhage in high-risk patients.
METHODS: A population-based nested case-control study was conducted within a cohort of new NSAID users with at least one risk factor for a NSAID-related UGI complication, identified in the Dutch IPCI database during 1996-2005. Adherence to GPAs was calculated as the proportion of NSAID treatment days covered (PDC) by a GPA prescription. Multivariate conditional logistic regression analysis was used to calculate odds ratios with 95% confidence intervals (95% CI).
RESULTS: Fifteen percent of the non-selective NSAID users received GPAs. The risk of a NSAID-related UGI complication among NSAID users increased 16% for every 10% decrease in adherence. Compared to patients with a PDC of >80%, patients with PDCs of 20-80% and <20% had a 2.5-fold (95% CI: 1.0-6.7) respectively 4.0-fold (95% CI: 1.2-13.0) increased risk.
CONCLUSION: There is a strong inverse relationship between adherence to GPAs and the risk of UGI complications in high-risk NSAID users.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17593072     DOI: 10.1111/j.1365-2036.2007.03358.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  23 in total

1.  Association between adherence to evidence-based guidelines for the prescription of non-steroidal anti-inflammatory drugs and the incidence of gastric mucosal lesions in Japanese patients.

Authors:  Hidetaka Tsumura; Tsuyoshi Fujita; Isamu Tamura; Yoshinori Morita; Masaru Yoshida; Takashi Toyonaga; Hidekazu Mukai; Hideto Inokuchi; Hiromu Kutsumi; Takeshi Azuma
Journal:  J Gastroenterol       Date:  2010-05-25       Impact factor: 7.527

2.  Primary prevention of adverse gastroduodenal effects from short-term use of non-steroidal anti-inflammatory drugs by omeprazole 20 mg in healthy subjects: a randomized, double-blind, placebo-controlled study.

Authors:  Jay C Desai; Shefali M Sanyal; Tyralee Goo; Ariel A Benson; Carol A Bodian; Kenneth M Miller; Lawrence B Cohen; James Aisenberg
Journal:  Dig Dis Sci       Date:  2008-01-26       Impact factor: 3.199

Review 3.  Optimal management of peptic ulcer disease in the elderly.

Authors:  Alberto Pilotto; Marilisa Franceschi; Stefania Maggi; Filomena Addante; Daniele Sancarlo
Journal:  Drugs Aging       Date:  2010-07-01       Impact factor: 3.923

4.  One fifth of hospitalizations for peptic ulcer-related bleeding are potentially preventable.

Authors:  Ray Boyapati; Sim Ye Ong; Bei Ye; Anuk Kruavit; Nora Lee; Rhys Vaughan; Sanjay Nandurkar; Peter Gibson; Mayur Garg
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

5.  Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?

Authors:  G M C Masclee; V E Valkhoff; E M van Soest; R Schade; G Mazzaglia; M Molokhia; G Trifirò; J L Goldstein; S Hernández-Díaz; E J Kuipers; M C J M Sturkenboom
Journal:  Aliment Pharmacol Ther       Date:  2013-05-28       Impact factor: 8.171

6.  Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies.

Authors:  Dominick J Angiolillo; Catherine Datto; Shane Raines; Neville D Yeomans
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

7.  Acute upper gastrointestinal bleeding in octogenarians: clinical outcome and factors related to mortality.

Authors:  George J Theocharis; Vassiliki Arvaniti; Stelios F Assimakopoulos; Konstantinos C Thomopoulos; Vassilis Xourgias; Irini Mylonakou; Vassiliki N Nikolopoulou
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

8.  Adherence with regulatory resolutions on prevention of NSAIDS-related gastrointestinal injury in Italy.

Authors:  Sabrina Montagnani; Marco Tuccori; Arianna Testi; Michele Cristofano; Tiberio Corona; Stefano Salvadori; Carmelo Scarpignato; Corrado Blandizzi
Journal:  Int J Clin Pharm       Date:  2016-03-22

Review 9.  Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.

Authors:  Marco Lazzaroni; Gabriele Bianchi Porro
Journal:  Drugs       Date:  2009       Impact factor: 9.546

10.  Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers.

Authors:  Loren Laine; Alan J Kivitz; Alfonso E Bello; Amy Y Grahn; Michael H Schiff; Ali S Taha
Journal:  Am J Gastroenterol       Date:  2011-12-20       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.